Primary Job Title Founder Primary Organization 
Araim Pharmaceuticals
Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn
Anthony Cerami has had a successful career applying detailed biochemical insights into understanding the pathogenesis of disease and translating these discoveries into novel therapeutic products that have wide clinical utility. He received his PhD from The Rockefeller University, completed a postdoctoral fellowship at Harvard Medical School, and
has received three honorary doctorates. Anthony Cerami was the Dean of Graduate and Postgraduate Studies at Rockefeller University. He established what is now the Feinstein Institute for Medical Research.
Anthony Cerami has been the inventor or co-inventor of more than 150 issued US patents and hundreds of foreign counterparts, including the anti-TNF monoclonal antibody approved by the FDA for the treatment of Crohn’s disease, rheumatoid arthritis, and psoriasis. Anti-TNF therapies are blockbuster drugs with more than $100 billion in sales. Anthony Cerami is also the inventor of the hemoglobin A1c test that is used by people with diabetes worldwide. In addition, he has authored or coauthored more than 500 scientific publications.
